Mytos

Mytos is a contract development and manufacturing organization (CDMO) for regenerative medicine and cell therapy. Its iDEM automation platform automates every unit operation of cell culture — coating, seeding, feeding, imaging, passaging and harvesting — in standard 2D T-flask formats, letting clinical-stage biotech companies transfer their manual protocols to automated GMP production at up to 50% lower batch cost, with 10x less labor and cleanroom footprint per batch. Mytos operates a CDMO facility within the Cell and Gene Therapy Catapult site and is backed by Wing Venture Capital. No public developer/API surface was found during enrichment; the profile captures the company's verified security posture (trust center, SOC 2/SOC 3/21 CFR Part 11, domain security, vulnerability disclosure).

Mytos is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Cell Therapy, Regenerative Medicine, and Manufacturing Automation.

🌐 Visit website 📡 Source on GitHub
15.1/100 emerging ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyBiotechnologyCell TherapyRegenerative MedicineManufacturing AutomationCDMOLife Sciences

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 15.1/100 · emerging
Contract Quality 0.0 / 25
Developer Ergonomics 0.0 / 20
Commercial Clarity 3.2 / 20
Operational Transparency 1.4 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/mytos: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 3

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Mytos Domain Security

TLSv1.3 · HSTS · DMARC

SECURITY

Mytos Vulnerability Disclosure

contact published

SECURITY

Mytos Trust Center

SOC 2 Type 2 (2025), SOC 3 (2025), 21 CFR Part 11

SECURITY

Resources

Access & Security 5

Authentication, authorization, and security posture

TrustCenter
TrustCenter
 Compliance
Compliance
 Security
Security
 VulnerabilityDisclosure
VulnerabilityDisclosure
 DomainSecurity
DomainSecurity

Company 1

The organization behind the API

Website
Website

Source (apis.yml)

apis.yml Raw ↑ 
aid: mytos
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/mytos.png
name: Mytos
description: Mytos is a contract development and manufacturing organization (CDMO) for regenerative medicine and cell therapy.
  Its iDEM automation platform automates every unit operation of cell culture — coating, seeding, feeding, imaging, passaging
  and harvesting — in standard 2D T-flask formats, letting clinical-stage biotech companies transfer their manual protocols
  to automated GMP production at up to 50% lower batch cost, with 10x less labor and cleanroom footprint per batch. Mytos
  operates a CDMO facility within the Cell and Gene Therapy Catapult site and is backed by Wing Venture Capital. No public
  developer/API surface was found during enrichment; the profile captures the company's verified security posture (trust center,
  SOC 2/SOC 3/21 CFR Part 11, domain security, vulnerability disclosure).
url: https://raw.githubusercontent.com/api-evangelist/mytos/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- wing-venture-capital
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-20'
tags:
- Company
- Biotechnology
- Cell Therapy
- Regenerative Medicine
- Manufacturing Automation
- CDMO
- Life Sciences
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://www.mytos.bio/
- type: TrustCenter
  url: security/mytos-trust-center.yml
- type: Compliance
  url: https://trust.mytos.bio/
- type: Security
  url: https://trust.mytos.bio/
- type: VulnerabilityDisclosure
  url: security/mytos-vulnerability-disclosure.yml
- type: DomainSecurity
  url: security/mytos-domain-security.yml
x-enrichment:
  date: '2026-07-20'
  status: enriched
  artifacts_added: 3
  pass: local-v1